BCAB · ISSUER CIK 1826892
BioAtla, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 BioAtla, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 202617:28 | Aug 31, 2026 | BCAB | Chief Medical Officer | F · Tax | $1.69 | −134 | 11,346 | -1% | $226.46 | ||
| Sep 2, 202617:27 | Aug 31, 2026 | BCAB | Chief Executive Officer, Director | F · Tax | $1.69 | −259 | 52,035 | -0% | $437.71 | ||
| Sep 2, 202617:26 | Aug 31, 2026 | BCAB | Chief Financial Officer | F · Tax | $1.69 | −71 | 10,476 | -1% | $119.99 |